$PCRX
Pacira Biosciences Inc Stock $pcrx

$pcrx Overview Financials Valuation SEC Filings Company Website

2022 Q3 Form 10-Q Financial Statement

#000139681422000050 Filed on August 03, 2022

Income Statement

Concept	2022 Q3	2022 Q2	2022 Q1
Revenue	$167.5M	$169.4M	$158.0M
YoY Change	31.12%	24.94%	32.74%
Cost Of Revenue	$50.68M	$50.63M	$36.07M
YoY Change	46.25%	43.63%	15.07%
Gross Profit	$116.8M	$118.8M	$121.9M
YoY Change	25.48%	18.38%	39.05%
Gross Profit Margin	69.74%	70.12%	77.17%
Selling, General & Admin	$61.28M	$65.00M	$64.26M
YoY Change	25.56%	27.93%	32.43%
% of Gross Profit	52.47%	54.72%	52.71%
Research & Development	$19.41M	$26.28M	$21.61M
YoY Change	67.6%	109.04%	36.06%
% of Gross Profit	16.62%	22.13%	17.72%
Depreciation & Amortization	$5.800M	$6.500M	$20.03M
YoY Change	52.63%	124.14%	312.97%
% of Gross Profit	4.97%	5.47%	16.43%
Operating Expenses	$80.69M	$91.29M	$85.87M
YoY Change	33.62%	44.01%	33.33%
Operating Profit	$21.29M	$31.24M	$17.39M
YoY Change	-32.27%	-10.36%	-10.52%
Interest Expense	$9.856M	$8.833M	$10.25M
YoY Change	34.41%	25.77%	46.98%
% of Operating Profit	46.3%	28.28%	58.91%
Other Income/Expense, Net	-$19.22M	-$9.228M	-$10.10M
YoY Change	166.87%	0.36%	50.44%
Pretax Income	$2.069M	$22.01M	$7.294M
YoY Change	-91.46%	-14.2%	-42.68%
Income Tax	$2.762M	$2.131M	$500.0K
% Of Pretax Income	133.49%	9.68%	6.85%
Net Earnings	-$693.0K	$19.88M	$6.828M
YoY Change	-103.92%	4.17%	-34.15%
Net Earnings / Revenue	-0.41%	11.73%	4.32%
Basic Earnings Per Share	-$0.02	$0.44	$0.15
Diluted Earnings Per Share	-$0.02	$0.40	$0.15
COMMON SHARES
Basic Shares Outstanding	45.82M shares	45.50M shares	44.87M shares
Diluted Shares Outstanding	45.83M shares	52.48M shares	46.44M shares

Balance Sheet

Concept	2022 Q3	2022 Q2	2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$328.7M	$316.4M	$452.2M
YoY Change	-52.62%	-51.07%	-23.37%
Cash & Equivalents	$109.4M	$122.1M	$226.8M
Short-Term Investments	$219.3M	$194.3M	$225.4M
Other Short-Term Assets	$14.42M	$18.12M	$19.06M
YoY Change	27.46%	46.6%	46.61%
Inventory	$96.80M	$100.6M	$103.7M
Prepaid Expenses
Receivables	$93.47M	$91.11M	$92.10M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$533.4M	$526.2M	$667.0M
YoY Change	-35.14%	-33.61%	-7.39%
LONG-TERM ASSETS
Property, Plant & Equipment	$193.6M	$191.3M	$189.8M
YoY Change	21.61%	24.77%	31.03%
Goodwill	$157.4M	$146.1M	$145.7M
YoY Change	58.19%	46.83%	46.43%
Intangibles	$581.0M	$595.3M	$609.6M
YoY Change	541.13%	542.98%	544.76%
Long-Term Investments	$43.75M	$35.81M	$35.77M
YoY Change	106.46%	99.33%	-29.86%
Other Assets	$155.5M	$167.1M	$169.3M
YoY Change	66.76%	69.52%	61.99%
Total Long-Term Assets	$1.201B	$1.208B	$1.224B
YoY Change	125.05%	126.49%	115.84%
TOTAL ASSETS
Total Short-Term Assets	$533.4M	$526.2M	$667.0M
Total Long-Term Assets	$1.201B	$1.208B	$1.224B
Total Assets	$1.734B	$1.734B	$1.891B
YoY Change	27.9%	30.78%	46.91%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$12.93M	$13.98M	$14.84M
YoY Change	63.81%	14.81%	62.93%
Accrued Expenses	$76.36M	$77.28M	$87.67M
YoY Change	50.31%	48.14%	74.5%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$33.87M	$33.78M	$193.7M
YoY Change	-78.25%	-78.02%	27.76%
Total Short-Term Liabilities	$131.5M	$133.2M	$305.1M
YoY Change	-41.75%	-41.77%	31.45%
LONG-TERM LIABILITIES
Long-Term Debt	$714.0M	$721.9M	$729.7M
YoY Change	118.92%	124.39%	129.99%
Other Long-Term Liabilities	$19.11M	$19.47M	$10.72M
YoY Change	153.04%	152.99%	102.76%
Total Long-Term Liabilities	$19.11M	$19.47M	$10.72M
YoY Change	153.04%	152.99%	102.76%
TOTAL LIABILITIES
Total Short-Term Liabilities	$131.5M	$133.2M	$305.1M
Total Long-Term Liabilities	$19.11M	$19.47M	$10.72M
Total Liabilities	$964.2M	$977.4M	$1.182B
YoY Change	51.28%	53.03%	85.62%
SHAREHOLDERS EQUITY
Retained Earnings	-$138.6M	-$138.0M	-$157.8M
YoY Change	-32.94%	-38.53%	-35.18%
Common Stock	$46.00K	$46.00K	$45.00K
YoY Change	2.22%	4.55%	2.27%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$770.1M	$756.6M	$709.6M
YoY Change
Total Liabilities & Shareholders Equity	$1.734B	$1.734B	$1.891B
YoY Change	27.9%	30.78%	46.91%

Cashflow Statement

Concept	2022 Q3	2022 Q2	2022 Q1
OPERATING ACTIVITIES
Net Income	-$693.0K	$19.88M	$6.828M
YoY Change	-103.92%	4.17%	-34.15%
Depreciation, Depletion And Amortization	$5.800M	$6.500M	$20.03M
YoY Change	52.63%	124.14%	312.97%
Cash From Operating Activities	$42.65M	$29.81M	$30.78M
YoY Change	-29.25%	-1.09%	154.76%
INVESTING ACTIVITIES
Capital Expenditures	-$5.181M	-$11.74M	$7.668M
YoY Change	-60.38%	11.19%	-41.34%
Acquisitions
YoY Change
Other Investing Activities	-$42.33M	$30.90M	-$200.4M
YoY Change	92.42%	127.46%	370.42%
Cash From Investing Activities	-$47.52M	$19.16M	-$208.0M
YoY Change	35.46%	532.59%	273.7%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-7.775M	-153.7M	-$181.6M
YoY Change	-354.75%	-2703.03%	-1858.69%
NET CHANGE
Cash From Operating Activities	42.65M	29.81M	$30.78M
Cash From Investing Activities	-47.52M	19.16M	-$208.0M
Cash From Financing Activities	-7.775M	-153.7M	-$181.6M
Net Change In Cash	-12.64M	-104.7M	-$358.8M
YoY Change	-144.71%	-367.98%	978.92%
FREE CASH FLOW
Cash From Operating Activities	$42.65M	$29.81M	$30.78M
Capital Expenditures	-$5.181M	-$11.74M	$7.668M
Free Cash Flow	$47.84M	$41.54M	$23.11M
YoY Change	-34.8%	2.09%	-2429.54%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Entity Central Index Key EntityCentralIndexKey	0001396814
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Amendment Flag AmendmentFlag	false
CY2021	us-gaap	Accounting Standards Update Extensible List AccountingStandardsUpdateExtensibleList	http://fasb.org/us-gaap/2022#AccountingStandardsUpdate202006RetrospectiveMember
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2022-06-30
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-35060
	dei	Entity Registrant Name EntityRegistrantName	PACIRA BIOSCIENCES, INC.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	51-0619477
	dei	Entity Address Address Line1 EntityAddressAddressLine1	5401 West Kennedy Boulevard, Suite 890
	dei	Entity Address City Or Town EntityAddressCityOrTown	Tampa
	dei	Entity Address State Or Province EntityAddressStateOrProvince	FL
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	33609
	dei	City Area Code CityAreaCode	813
	dei	Local Phone Number LocalPhoneNumber	553-6680
	dei	Security12b Title Security12bTitle	Common Stock, par value $0.001 per share
	dei	Trading Symbol TradingSymbol	PCRX
	dei	Security Exchange Name SecurityExchangeName	NASDAQ
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	false
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2022Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	45824210	shares
CY2022Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	122061000	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	585578000	usd
CY2022Q2	us-gaap	Short Term Investments ShortTermInvestments	194332000	usd
CY2021Q4	us-gaap	Short Term Investments ShortTermInvestments	70831000	usd
CY2022Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	91105000	usd
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	96318000	usd
CY2022Q2	us-gaap	Inventory Net InventoryNet	100588000	usd
CY2021Q4	us-gaap	Inventory Net InventoryNet	98550000	usd
CY2022Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	18124000	usd
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	14771000	usd
CY2022Q2	us-gaap	Assets Current AssetsCurrent	526210000	usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	866048000	usd
CY2022Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	191279000	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	188401000	usd
CY2022Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	72082000	usd
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	76410000	usd
CY2022Q2	us-gaap	Goodwill Goodwill	146132000	usd
CY2021Q4	us-gaap	Goodwill Goodwill	145175000	usd
CY2022Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	595324000	usd
CY2021Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	623968000	usd
CY2022Q2	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	167149000	usd
CY2021Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	153364000	usd
CY2022Q2	pcrx	Equity Method Investments And Other Assets EquityMethodInvestmentsAndOtherAssets	35812000	usd
CY2021Q4	pcrx	Equity Method Investments And Other Assets EquityMethodInvestmentsAndOtherAssets	21987000	usd
CY2022Q2	us-gaap	Assets Assets	1733988000	usd
CY2021Q4	us-gaap	Assets Assets	2075353000	usd
CY2022Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	13983000	usd
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	10543000	usd
CY2022Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	77275000	usd
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	127555000	usd
CY2022Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	8134000	usd
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	7891000	usd
CY2022Q2	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	0	usd
CY2022Q2	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	0	usd
CY2021Q4	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	350466000	usd
CY2021Q4	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	350466000	usd
CY2022Q2	us-gaap	Secured Debt Current SecuredDebtCurrent	33776000	usd
CY2021Q4	us-gaap	Secured Debt Current SecuredDebtCurrent	24234000	usd
CY2022Q2	us-gaap	Taxes Payable Current TaxesPayableCurrent	11000	usd
CY2021Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	429000	usd
CY2022Q2	us-gaap	Liabilities Current LiabilitiesCurrent	133179000	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	521118000	usd
CY2022Q2	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent	403534000	usd
CY2021Q4	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent	339267000	usd
CY2022Q2	us-gaap	Secured Long Term Debt SecuredLongTermDebt	318344000	usd
CY2021Q4	us-gaap	Secured Long Term Debt SecuredLongTermDebt	335263000	usd
CY2022Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	67575000	usd
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	71727000	usd
CY2022Q2	pcrx	Contingent Consideration Noncurrent ContingentConsiderationNoncurrent	35247000	usd
CY2021Q4	pcrx	Contingent Consideration Noncurrent ContingentConsiderationNoncurrent	57598000	usd
CY2022Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	19473000	usd
CY2021Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	19972000	usd
CY2022Q2	us-gaap	Liabilities Liabilities	977352000	usd
CY2021Q4	us-gaap	Liabilities Liabilities	1344945000	usd
CY2022Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2022Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2022Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2021Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2021Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q2	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2021Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000	shares
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000	shares
CY2022Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	45801578	shares
CY2022Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	45801578	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	44734308	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	44734308	shares
CY2022Q2	us-gaap	Common Stock Value CommonStockValue	46000	usd
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	45000	usd
CY2022Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	895151000	usd
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	942091000	usd
CY2022Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-137956000	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-211895000	usd
CY2022Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-605000	usd
CY2021Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	167000	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	756636000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	730408000	usd
CY2022Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1733988000	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2075353000	usd
CY2022Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	169411000	usd
CY2021Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	135590000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	327402000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	254617000	usd
CY2022Q2	us-gaap	Cost Of Revenue CostOfRevenue	50627000	usd
CY2021Q2	us-gaap	Cost Of Revenue CostOfRevenue	35248000	usd
	us-gaap	Cost Of Revenue CostOfRevenue	86701000	usd
	us-gaap	Cost Of Revenue CostOfRevenue	66597000	usd
CY2022Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	26282000	usd
CY2021Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	12573000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	47887000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	28453000	usd
CY2022Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	65003000	usd
CY2021Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	50813000	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	129263000	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	99335000	usd
CY2022Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	14322000	usd
CY2021Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1967000	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	28644000	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	3933000	usd
CY2022Q2	pcrx	Acquisition Related Gain Loss Product Discontinuation Costs And Other Net AcquisitionRelatedGainLossProductDiscontinuationCostsAndOtherNet	18058000	usd
CY2021Q2	pcrx	Acquisition Related Gain Loss Product Discontinuation Costs And Other Net AcquisitionRelatedGainLossProductDiscontinuationCostsAndOtherNet	-146000	usd
	pcrx	Acquisition Related Gain Loss Product Discontinuation Costs And Other Net AcquisitionRelatedGainLossProductDiscontinuationCostsAndOtherNet	13721000	usd
CY2022Q2	us-gaap	Asset Retirement Obligation AssetRetirementObligation	3100000	usd
	pcrx	Acquisition Related Gain Loss Product Discontinuation Costs And Other Net AcquisitionRelatedGainLossProductDiscontinuationCostsAndOtherNet	-2019000	usd
CY2022Q2	us-gaap	Costs And Expenses CostsAndExpenses	138176000	usd
CY2021Q2	us-gaap	Costs And Expenses CostsAndExpenses	100747000	usd
	us-gaap	Costs And Expenses CostsAndExpenses	278774000	usd
	us-gaap	Costs And Expenses CostsAndExpenses	200337000	usd
CY2022Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	31235000	usd
CY2021Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	34843000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	48628000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	54280000	usd
CY2022Q2	us-gaap	Investment Income Interest InvestmentIncomeInterest	252000	usd
CY2021Q2	us-gaap	Investment Income Interest InvestmentIncomeInterest	224000	usd
	us-gaap	Investment Income Interest InvestmentIncomeInterest	523000	usd
	us-gaap	Investment Income Interest InvestmentIncomeInterest	639000	usd
CY2022Q2	us-gaap	Interest Expense InterestExpense	8833000	usd
CY2021Q2	us-gaap	Interest Expense InterestExpense	7023000	usd
	us-gaap	Interest Expense InterestExpense	19079000	usd
	us-gaap	Interest Expense InterestExpense	13994000	usd
CY2022Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-647000	usd
CY2021Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-2396000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-771000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-2554000	usd
CY2022Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-9228000	usd
CY2021Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-9195000	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-19327000	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-15909000	usd
CY2022Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	22007000	usd
CY2021Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	25648000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	29301000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	38371000	usd
CY2022Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2131000	usd
CY2021Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	6567000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2597000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	8921000	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	19876000	usd
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	19081000	usd
	us-gaap	Net Income Loss NetIncomeLoss	26704000	usd
	us-gaap	Net Income Loss NetIncomeLoss	29450000	usd
CY2022Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.44
CY2021Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.43
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.59
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.67
CY2022Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.40
CY2021Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.42
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.55
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.64
CY2022Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	45501000	shares
CY2021Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	44145000	shares
	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	2100000	usd
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	45185000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	43989000	shares
CY2022Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	52478000	shares
CY2021Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	45592000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	52262000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	45779000	shares
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	19876000	usd
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	19081000	usd
	us-gaap	Net Income Loss NetIncomeLoss	26704000	usd
	us-gaap	Net Income Loss NetIncomeLoss	29450000	usd
CY2022Q2	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-160000	usd
CY2021Q2	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	12000	usd
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-893000	usd
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-138000	usd
CY2022Q2	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	82000	usd
CY2021Q2	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-3000	usd
	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	121000	usd
	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	1000	usd
CY2022Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-78000	usd
CY2021Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	9000	usd
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-772000	usd
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-137000	usd
CY2022Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	19798000	usd
CY2021Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	19090000	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	25932000	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	29313000	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	709576000	usd
CY2022Q2	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	10857000	usd
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue	0	usd
CY2022Q2	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	1821000	usd
CY2022Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	11544000	usd
CY2022Q2	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	3040000	usd
CY2022Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-78000	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	19876000	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	756636000	usd
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	650818000	usd
CY2021Q2	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	5225000	usd
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue	0	usd
CY2021Q2	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	1574000	usd
CY2021Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	10461000	usd
CY2021Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	9000	usd
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	19081000	usd
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	687168000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	730408000	usd
	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	21935000	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue	0	usd
	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	1821000	usd
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	22733000	usd
	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	3040000	usd
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-772000	usd
	us-gaap	Net Income Loss NetIncomeLoss	26704000	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	756636000	usd
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	619688000	usd
	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	16022000	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue	0	usd
	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	1574000	usd
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	20571000	usd
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-137000	usd
	us-gaap	Net Income Loss NetIncomeLoss	29450000	usd
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	687168000	usd
	us-gaap	Net Income Loss NetIncomeLoss	26704000	usd
	us-gaap	Net Income Loss NetIncomeLoss	29450000	usd
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	2193000	usd
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	7613000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	40897000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	9748000	usd
	pcrx	Amortization Of Other Assets And Unfavorable Lease Obligation AmortizationOfOtherAssetsAndUnfavorableLeaseObligation	2053000	usd
	pcrx	Amortization Of Other Assets And Unfavorable Lease Obligation AmortizationOfOtherAssetsAndUnfavorableLeaseObligation	1310000	usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	1412000	usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	11401000	usd
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-193000	usd
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	10000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	22733000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	20571000	usd
	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-22351000	usd
	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-988000	usd
	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	108000	usd
	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	2601000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-5213000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	15312000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	2038000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	615000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	3233000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	944000	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	5258000	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	2156000	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-19038000	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-18140000	usd
	us-gaap	Gain Loss On Investments GainLossOnInvestments	-479000	usd
	us-gaap	Gain Loss On Investments GainLossOnInvestments	964000	usd
	us-gaap	Payment For Contingent Consideration Liability Operating Activities PaymentForContingentConsiderationLiabilityOperatingActivities	0	usd
	us-gaap	Payment For Contingent Consideration Liability Operating Activities PaymentForContingentConsiderationLiabilityOperatingActivities	5662000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	60583000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	42215000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	19403000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	23624000	usd
	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	187641000	usd
	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	318132000	usd
	us-gaap	Proceeds From Sale Of Short Term Investments ProceedsFromSaleOfShortTermInvestments	62936000	usd
	us-gaap	Proceeds From Sale Of Short Term Investments ProceedsFromSaleOfShortTermInvestments	294288000	usd
	pcrx	Payment Of Contingent Consideration PaymentOfContingentConsideration	32000000	usd
	pcrx	Payment Of Contingent Consideration PaymentOfContingentConsideration	0	usd
	us-gaap	Payments To Acquire Longterm Investments PaymentsToAcquireLongtermInvestments	12750000	usd
	us-gaap	Payments To Acquire Longterm Investments PaymentsToAcquireLongtermInvestments	14220000	usd
	us-gaap	Proceeds From Sale Of Longterm Investments ProceedsFromSaleOfLongtermInvestments	0	usd
	us-gaap	Proceeds From Sale Of Longterm Investments ProceedsFromSaleOfLongtermInvestments	9057000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-188858000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-52631000	usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	21881000	usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	15997000	usd
	pcrx	Proceeds From Shares Issued Under Employee Stock Purchase Plans ProceedsFromSharesIssuedUnderEmployeeStockPurchasePlans	1821000	usd
	pcrx	Proceeds From Shares Issued Under Employee Stock Purchase Plans ProceedsFromSharesIssuedUnderEmployeeStockPurchasePlans	1574000	usd
	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	9375000	usd
	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	0	usd
	us-gaap	Payment For Contingent Consideration Liability Financing Activities PaymentForContingentConsiderationLiabilityFinancingActivities	0	usd
	us-gaap	Payment For Contingent Consideration Liability Financing Activities PaymentForContingentConsiderationLiabilityFinancingActivities	1338000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-335242000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	16233000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-463517000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	5817000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	585578000	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	99957000	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	122061000	usd
CY2021Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	105774000	usd
	us-gaap	Interest Paid Net InterestPaidNet	14686000	usd
	us-gaap	Interest Paid Net InterestPaidNet	3586000	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	4104000	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	1447000	usd
	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	3040000	usd
	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	0	usd
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	2454000	usd
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	8096000	usd
	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	1	segment
	pcrx	Business Combination Provisional Information Initial Accounting Incomplete Adjustment Assets BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssets	0	usd
	pcrx	Business Combination Provisional Information Initial Accounting Incomplete Adjustment Accrued Expenses BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccruedExpenses	957000	usd
	pcrx	Business Combination Provisional Information Initial Accounting Incomplete Adjustment Liabilities BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilities	957000	usd
	pcrx	Business Combination Provisional Information Initial Accounting Incomplete Adjustment Net Assets BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetAssets	-957000	usd
	us-gaap	Goodwill Purchase Accounting Adjustments GoodwillPurchaseAccountingAdjustments	957000	usd
	us-gaap	Business Combination Provisional Information Initial Accounting Incomplete Adjustment Consideration Transferred BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred	0	usd
CY2021Q2	us-gaap	Business Acquisition Pro Forma Earnings Per Share Basic BusinessAcquisitionProFormaEarningsPerShareBasic	-0.08
CY2021Q2	us-gaap	Business Acquisition Pro Forma Earnings Per Share Diluted BusinessAcquisitionProFormaEarningsPerShareDiluted	-0.08
CY2022Q2	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	36301000	usd
CY2021Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	36337000	usd
CY2022Q2	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	39407000	usd
CY2021Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	35182000	usd
CY2022Q2	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	24880000	usd
CY2021Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	27031000	usd
CY2022Q2	us-gaap	Inventory Net InventoryNet	100588000	usd
CY2021Q4	us-gaap	Inventory Net InventoryNet	98550000	usd
CY2022Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	286752000	usd
CY2021Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	273641000	usd
CY2022Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	95473000	usd
CY2021Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	85240000	usd
CY2022Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	191279000	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	188401000	usd
CY2022Q2	us-gaap	Depreciation Depreciation	6500000	usd
CY2021Q2	us-gaap	Depreciation Depreciation	2900000	usd
	us-gaap	Depreciation Depreciation	12200000	usd
	us-gaap	Depreciation Depreciation	5800000	usd
	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	1800000	usd
CY2021Q4	us-gaap	Asset Retirement Obligation AssetRetirementObligation	2400000	usd
CY2022Q2	pcrx	Number Of Leases NumberOfLeases	2	lease
CY2022Q2	us-gaap	Operating Lease Cost OperatingLeaseCost	3542000	usd
CY2021Q2	us-gaap	Operating Lease Cost OperatingLeaseCost	2922000	usd
	us-gaap	Operating Lease Cost OperatingLeaseCost	7069000	usd
	us-gaap	Operating Lease Cost OperatingLeaseCost	5843000	usd
CY2022Q2	us-gaap	Variable Lease Cost VariableLeaseCost	508000	usd
CY2021Q2	us-gaap	Variable Lease Cost VariableLeaseCost	424000	usd
	us-gaap	Variable Lease Cost VariableLeaseCost	980000	usd
	us-gaap	Variable Lease Cost VariableLeaseCost	902000	usd
CY2022Q2	us-gaap	Lease Cost LeaseCost	4050000	usd
CY2021Q2	us-gaap	Lease Cost LeaseCost	3346000	usd
	us-gaap	Lease Cost LeaseCost	8049000	usd
	us-gaap	Lease Cost LeaseCost	6745000	usd
	us-gaap	Operating Lease Payments OperatingLeasePayments	6637000	usd
	us-gaap	Operating Lease Payments OperatingLeasePayments	7177000	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	0	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	0	usd
CY2022Q2	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P7Y3M29D
CY2021Q2	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P8Y8M15D
CY2022Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0695
CY2021Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0689
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	6509000	usd
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	13304000	usd
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	13435000	usd
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	12575000	usd
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	12310000	usd
CY2021Q4	us-gaap	Goodwill Goodwill	145200000	usd
CY2022Q2	pcrx	Lessee Operating Lease Liability To Be Paid After Year Four LesseeOperatingLeaseLiabilityToBePaidAfterYearFour	39422000	usd
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	97555000	usd
CY2022Q2	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	21846000	usd
CY2022Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	75709000	usd
	pcrx	Lessee Operating Lease Lease Not Yet Commenced Number Of Contracts LesseeOperatingLeaseLeaseNotYetCommencedNumberOfContracts	1	segment
CY2022Q2	pcrx	Lessee Operating Lease Lease Not Yet Commenced Liability Remainder Of Fiscal Year LesseeOperatingLeaseLeaseNotYetCommencedLiabilityRemainderOfFiscalYear	81000	usd
CY2022Q2	pcrx	Lessee Operating Lease Lease Not Yet Commenced Liability Due Year One LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearOne	492000	usd
CY2022Q2	pcrx	Lessee Operating Lease Lease Not Yet Commenced Liability Due Year Two LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearTwo	494000	usd
CY2022Q2	pcrx	Lessee Operating Lease Lease Not Yet Commenced Liability Due Year Three LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearThree	503000	usd
CY2022Q2	pcrx	Lessee Operating Lease Lease Not Yet Commenced Liability Due Year Four LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearFour	505000	usd
CY2022Q2	pcrx	Lessee Operating Lease Lease Not Yet Commenced Liability Due After Year Four LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueAfterYearFour	443000	usd
CY2022Q2	pcrx	Lessee Operating Lease Lease Not Yet Commenced Liability LesseeOperatingLeaseLeaseNotYetCommencedLiability	2518000	usd
CY2022Q2	us-gaap	Goodwill Goodwill	146100000	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	590090000	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	55766000	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	534324000	usd
CY2022Q2	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	651090000	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	55766000	usd
CY2022Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	595324000	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	590090000	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	27122000	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	562968000	usd
CY2021Q4	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	651090000	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	27122000	usd
CY2021Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	623968000	usd
CY2022Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	14300000	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	28600000	usd
CY2021Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	2000000	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	3900000	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	28600000	usd
CY2022Q2	pcrx	Finite Lived Intangible Assets Amortization Expense Annual Amount Period1 FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod1	57300000	usd
CY2022Q2	pcrx	Finite Lived Intangible Assets Amortization Expense Annual Amount Period2 FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod2	37400000	usd
CY2022Q2	pcrx	Finite Lived Intangible Assets Amortization Expense Annual Amount Period3 FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod3	7900000	usd
CY2022Q2	pcrx	Finite Lived Intangible Assets Amortization Expense Annual Amount Period4 FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod4	2200000	usd
	pcrx	Settlement Period Convertible Debt Conversion Request SettlementPeriodConvertibleDebtConversionRequest	P40D
CY2022Q2	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	8196000	usd
CY2021Q2	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	1713000	usd
	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	17381000	usd
	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	3418000	usd
CY2022Q2	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	874000	usd
CY2021Q2	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	659000	usd
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	2053000	usd
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	1310000	usd
CY2022Q2	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	706000	usd
CY2021Q2	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	5744000	usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	1412000	usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	11401000	usd
CY2022Q2	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	943000	usd
CY2021Q2	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	1093000	usd
	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	1767000	usd
	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	2135000	usd
CY2022Q2	us-gaap	Interest Expense Debt InterestExpenseDebt	8833000	usd
CY2021Q2	us-gaap	Interest Expense Debt InterestExpenseDebt	7023000	usd
	us-gaap	Interest Expense Debt InterestExpenseDebt	19079000	usd
	us-gaap	Interest Expense Debt InterestExpenseDebt	13994000	usd
CY2022Q2	us-gaap	Debt Instrument Interest Rate During Period DebtInstrumentInterestRateDuringPeriod	0.0508
CY2021Q2	us-gaap	Debt Instrument Interest Rate During Period DebtInstrumentInterestRateDuringPeriod	0.0670
	us-gaap	Debt Instrument Interest Rate During Period DebtInstrumentInterestRateDuringPeriod	0.0531
	us-gaap	Debt Instrument Interest Rate During Period DebtInstrumentInterestRateDuringPeriod	0.0670
CY2022Q2	us-gaap	Share Price SharePrice	58.30
CY2021Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	18259000	usd
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Purchases FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases	12750000	usd
	pcrx	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Foreign Currency Gain Loss FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetForeignCurrencyGainLoss	-83000	usd
CY2022Q2	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	30926000	usd
CY2022Q2	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	195430000	usd
CY2022Q2	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	0	usd
CY2022Q2	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	1098000	usd
CY2022Q2	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	194332000	usd
CY2022Q2	us-gaap	Interest Receivable InterestReceivable	200000	usd
CY2021Q4	us-gaap	Interest Receivable InterestReceivable	100000	usd
	pcrx	Number Of Major Customers NumberOfMajorCustomers	3	customer
CY2021	pcrx	Number Of Major Customers NumberOfMajorCustomers	4	segment
CY2022Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	0	usd
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	0	usd
CY2022Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	11544000	usd
CY2021Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	10461000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	22733000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	20571000	usd
CY2022Q2	pcrx	Compensationexpensefromstockoptionsemployees Compensationexpensefromstockoptionsemployees	6542000	usd
CY2021Q2	pcrx	Compensationexpensefromstockoptionsemployees Compensationexpensefromstockoptionsemployees	6552000	usd
	pcrx	Compensationexpensefromstockoptionsemployees Compensationexpensefromstockoptionsemployees	13327000	usd
	pcrx	Compensationexpensefromstockoptionsemployees Compensationexpensefromstockoptionsemployees	13048000	usd
CY2022Q2	us-gaap	Restricted Stock Expense RestrictedStockExpense	4717000	usd
CY2021Q2	us-gaap	Restricted Stock Expense RestrictedStockExpense	3646000	usd
	us-gaap	Restricted Stock Expense RestrictedStockExpense	8830000	usd
	us-gaap	Restricted Stock Expense RestrictedStockExpense	7038000	usd
CY2022Q2	pcrx	Compensation Expense From Employee Stock Purchase Plan CompensationExpenseFromEmployeeStockPurchasePlan	285000	usd
CY2021Q2	pcrx	Compensation Expense From Employee Stock Purchase Plan CompensationExpenseFromEmployeeStockPurchasePlan	263000	usd
	pcrx	Compensation Expense From Employee Stock Purchase Plan CompensationExpenseFromEmployeeStockPurchasePlan	576000	usd
	pcrx	Compensation Expense From Employee Stock Purchase Plan CompensationExpenseFromEmployeeStockPurchasePlan	485000	usd
CY2022Q2	us-gaap	Share Based Compensation ShareBasedCompensation	11544000	usd
CY2021Q2	us-gaap	Share Based Compensation ShareBasedCompensation	10461000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	22733000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	20571000	usd
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	6050540	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	49.32
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	1010780	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	60.22
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	630413	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	34.80
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	54215	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	52.41
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	13054	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	85.48
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	6363638	shares
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	52.39
CY2021Q2	us-gaap	Net Income Loss Attributable To Parent Diluted NetIncomeLossAttributableToParentDiluted	19081000	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	25.69
CY2022Q2	pcrx	Employee Stock Purchase Plans Shares Amount Authorized To Be Sold During Period Increase EmployeeStockPurchasePlansSharesAmountAuthorizedToBeSoldDuringPeriodIncrease	500000	shares
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Purchase Price Of Common Stock Percent SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent	0.85
	us-gaap	Stock Issued During Period Shares Employee Stock Purchase Plans StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans	36729	shares
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	19876000	usd
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	19081000	usd
	us-gaap	Net Income Loss NetIncomeLoss	26704000	usd
	us-gaap	Net Income Loss NetIncomeLoss	29450000	usd
CY2022Q2	us-gaap	Dilutive Securities Effect On Basic Earnings Per Share Other DilutiveSecuritiesEffectOnBasicEarningsPerShareOther	1039000	usd
CY2021Q2	us-gaap	Dilutive Securities Effect On Basic Earnings Per Share Other DilutiveSecuritiesEffectOnBasicEarningsPerShareOther	0	usd
	us-gaap	Dilutive Securities Effect On Basic Earnings Per Share Other DilutiveSecuritiesEffectOnBasicEarningsPerShareOther	2078000	usd
	us-gaap	Dilutive Securities Effect On Basic Earnings Per Share Other DilutiveSecuritiesEffectOnBasicEarningsPerShareOther	0	usd
CY2022Q2	us-gaap	Net Income Loss Attributable To Parent Diluted NetIncomeLossAttributableToParentDiluted	20915000	usd
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.59
	us-gaap	Net Income Loss Attributable To Parent Diluted NetIncomeLossAttributableToParentDiluted	28782000	usd
	us-gaap	Net Income Loss Attributable To Parent Diluted NetIncomeLossAttributableToParentDiluted	29450000	usd
CY2022Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	45501000	shares
CY2021Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	44145000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	45185000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	43989000	shares
CY2022Q2	us-gaap	Incremental Common Shares Attributable To Conversion Of Debt Securities IncrementalCommonSharesAttributableToConversionOfDebtSecurities	0	shares
CY2021Q2	us-gaap	Incremental Common Shares Attributable To Conversion Of Debt Securities IncrementalCommonSharesAttributableToConversionOfDebtSecurities	0	shares
	us-gaap	Incremental Common Shares Attributable To Conversion Of Debt Securities IncrementalCommonSharesAttributableToConversionOfDebtSecurities	0	shares
	us-gaap	Incremental Common Shares Attributable To Conversion Of Debt Securities IncrementalCommonSharesAttributableToConversionOfDebtSecurities	76000	shares
CY2022Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	52478000	shares
CY2021Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	45592000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	52262000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	45779000	shares
CY2022Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.44
CY2021Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.43
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.67
CY2022Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.40
CY2021Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.42
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.55
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.64
CY2022Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1979000	shares
CY2021Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	2114000	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	3075000	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1503000	shares
CY2022Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	23798000	usd
CY2021Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	25863000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	30380000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	41795000	usd
CY2022Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	-1791000	usd
CY2021Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	-215000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	-1079000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	-3424000	usd
CY2022Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	22007000	usd
CY2021Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	25648000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	29301000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	38371000	usd
CY2022Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2131000	usd
CY2021Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	6567000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2597000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	8921000	usd
CY2022Q2	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.10
CY2021Q2	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.26
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.09
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.23
CY2022Q2	us-gaap	Business Combination Integration Related Costs BusinessCombinationIntegrationRelatedCosts	950000	usd
CY2021Q2	us-gaap	Business Combination Integration Related Costs BusinessCombinationIntegrationRelatedCosts	0	usd
	us-gaap	Business Combination Integration Related Costs BusinessCombinationIntegrationRelatedCosts	4065000	usd
	us-gaap	Business Combination Integration Related Costs BusinessCombinationIntegrationRelatedCosts	0	usd
CY2022Q2	pcrx	Business Combination Acquisition And Integration Related Costs BusinessCombinationAcquisitionAndIntegrationRelatedCosts	3222000	usd
CY2021Q2	pcrx	Business Combination Acquisition And Integration Related Costs BusinessCombinationAcquisitionAndIntegrationRelatedCosts	7000	usd
	pcrx	Business Combination Acquisition And Integration Related Costs BusinessCombinationAcquisitionAndIntegrationRelatedCosts	8630000	usd
	pcrx	Business Combination Acquisition And Integration Related Costs BusinessCombinationAcquisitionAndIntegrationRelatedCosts	7000	usd
CY2022Q2	pcrx	Acquisition Related Charges Product Discontinuation And Other AcquisitionRelatedChargesProductDiscontinuationAndOther	-18058000	usd
CY2021Q2	pcrx	Acquisition Related Charges Product Discontinuation And Other AcquisitionRelatedChargesProductDiscontinuationAndOther	146000	usd
	pcrx	Acquisition Related Charges Product Discontinuation And Other AcquisitionRelatedChargesProductDiscontinuationAndOther	-13721000	usd
	pcrx	Acquisition Related Charges Product Discontinuation And Other AcquisitionRelatedChargesProductDiscontinuationAndOther	2019000	usd

Files In Submission

Name	View Source	Status
0001396814-22-000050-index-headers.html	Edgar Link	pending
0001396814-22-000050-index.html	Edgar Link	pending
0001396814-22-000050.txt	Edgar Link	pending
0001396814-22-000050-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
pcrx-20220630.htm	Edgar Link	pending
pcrx-20220630.xsd	Edgar Link	pending
pcrx-20220630_cal.xml	Edgar Link	unprocessable
pcrx-20220630_def.xml	Edgar Link	unprocessable
pcrx-20220630_g1.jpg	Edgar Link	pending
pcrx-20220630_g2.jpg	Edgar Link	pending
pcrx-20220630_htm.xml	Edgar Link	completed
pcrx-20220630_lab.xml	Edgar Link	unprocessable
pcrx-20220630_pre.xml	Edgar Link	unprocessable
pcrx-6302022xex311.htm	Edgar Link	pending
pcrx-6302022xex312.htm	Edgar Link	pending
pcrx-6302022xex321.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$PCRX
Pacira Biosciences Inc Stock $pcrx

2022 Q3 Form 10-Q Financial Statement

#000139681422000050 Filed on August 03, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PCRX Pacira Biosciences Inc Stock $pcrx

2022 Q3 Form 10-Q Financial Statement

#000139681422000050 Filed on August 03, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PCRX
Pacira Biosciences Inc Stock $pcrx